濮陽惠成(300481.SZ)擬投建順酐酸酐衍生物及電子化學品及研發中心項目
格隆匯1月3日丨濮陽惠成(300481.SZ)公佈,公司與福建漳州古雷港經濟開發區管理委員會本着平等互利、友好協商的原則,為了推動雙方資源共享、優勢互補,實現共同發展,於2020年1月3日簽署了《福建漳州古雷港經濟開發區濮陽惠成電子材料股份有限公司項目投資協議》。
已於2020年1月2日經公司第三屆董事會第二十二次會議審議通過《關於公司擬簽訂
<福建漳州古雷港經濟開發區投資協議>
的議案》。
福建漳州古雷港經濟開發區投資協議>
項目名稱:順酐酸酐衍生物及電子化學品及研發中心項目;項目投資額約10億元人民幣。位置和麪積:古雷港經濟開發區,總用地面積總面積約 180 畝(以實際出讓為準),分兩期建設。
該項目符合公司戰略發展需要,如順利實施將有利於提升未來發展空間,順酐酸酐衍生物產量的提升有助於提高公司的規模化效應,進一步打開公司降低單位產品成本的潛在空間,提高單位產品的毛利率。對於精細化工企業來説,成本的降低,毛利率的提升,將進一步改善企業的盈利能力,進一步鞏固公司在行業中的優勢地位,使公司的競爭優勢明顯。為公司持續發展提供支持和保障,為公司未來發展注入動力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.